AIM ImmunoTech Inc. 10-Q filing
Filed 2025-11-17 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-023894
- Form type
- 10-Q
- CIK
- 0000946644
- Primary document
- https://www.sec.gov/Archives/edgar/data/946644/000149315225023894/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AIM ImmunoTech Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $67,000 | - | - |
| Operating Income | $-8.7M | - | - |
| Net Income | $-9.8M | - | - |
| Eps Basic | -8.18 | - | - |
| Eps Diluted | -8.18 | - | - |
| Cash And Equivalents | $2.3M | - | - |
| Total Assets | $5.5M | - | - |
| Total Liabilities | $11.6M | - | - |
| Shareholders Equity | $-6.1M | - | - |
| Operating Cash Flow | $-9.0M | - | - |
| Capital Expenditures | $18,000 | - | - |